Recent advances in genotyping technologies have enabled analysis of over 600,000 SNPs across large sample sets which have allowed whole-genome disease-association studies. More recently, several studies have shown the prevalence of common copy number variants encompassing a large percentage of the human genome. Illumina has developed the Infinium whole-genome genotyping assay, which can be applied to the study of genome-wide copy number variants and other alterations such as homozygosity tracts and how they relate to human disease.

Geospiza, a trusted advisor to many of the world’s leading laboratories, releases white paper that describes in detail their confirmed approach for automating genetic testing. Download this free white paper to see how you can increase capacity by 4-fold or more without adding operational overhead.

How Beverly Enterprises realized a $6 million dollar ROI with new technology including HP Thin Clients. Beverly Enterprises, Inc's success is due in part to a focus on continual process improvement - always looking at ways of optimizing operations and making administrative functions more efficient. With that goal in mind Beverly Enterprises set out to streamline their technology platform. The result is a return-on-investment exceeding six million dollars while creating new technology efficiencies in relationship stability, customer service and reliability through the effective replacement of client and server equipment with solutions that included HP Thin Client. Download Now.